News and Press Releases
As of 31 March 2026, 14 patients have been enrolled in the trial. We are very much looking forward to further patients. Currently, eight sites in Germany are activated, and many more will follow in the coming weeks. The other countries are also in the final stages of preparing the trial and will begin in the coming months.
Trial teams of the sites who already enrolled patients
Hamburg
Berlin Vivantes
Lübeck
Lüneburg
Mannheim
Heidelberg
EAST-STROKE Podcast
The first EAST-STROKE Podcast with Götz Thomalla is now available on YouTube. In this episode, he presents the trial, outlining its background and objectives and discussing how its future results could influence clinical practice.
First patient successfully enrolled at UKE!
On 22 December 2025, the first patient has been successfully enrolled at University Medical Center Hamburg-Eppendorf (UKE)! What a great milestone, achieved just in time for Christmas. We wish everyone a Merry Christmas and are looking forward to [...]
First trial site activated on 6 November 2025!
On 6 November 2025 the first study site in Germany - University Medical Center Hamburg-Eppendord (UKE) - has been initiated! This marks an important milestone and the official start of many more site initiations to come [...]
EAST-STROKE Investigator Meeting – Hamburg, 16 October 2025
We were delighted to meet the EAST-STROKE investigators, study nurses and further trial team members from Germany, the Netherlands, Switzerland, and Spain. It was a great kick-off for the trial, with inspiring discussions and strong team [...]
Regulatory approval received for Germany, Spain, and the Netherlands!
We are very pleased to share that we’ve received regulatory approval via CTIS for Germany, Spain, and the Netherlands! 🎉 This marks a major milestone in the EAST-STROKE trial – and now we can truly get [...]
Meet EAST-STROKE at the DGK Herztage
Dr. Märit Jensen will be available Friday afternoon, September 26, at booth 41 (AFNET) to answer your questions about the EAST-STROKE trial. Come by for a personal exchange and learn more about the trial's background, goals, [...]
